Lilly's Mounjaro more popular than Wegovy in UK's private obesity drug market
Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...
What is Mounjaro? The Ozempic-style weight-loss drug being rolled out on the NHS
They’ve been heralded as the magic drugs that treat obesity when diet and exercise have failed. But Ozempic and Wegovy – and ...
Ozempic, Mounjaro and Wegovy - all your questions answered
Health Editor Amy Packer asks the medical experts to answer your most common questions about Ozempic, Mounjaro and Wegovy ...
Is Ozempic safe for weight loss? What doctors want you to know
Popular GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight, but what should patients know about ...
Weight loss costs: Iowans struggle with insurance and access to ozempic, other GLP-1 drugs
Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...
The Ozempic Flip-Flop
A few years ago, West Virginia, which has the highest obesity rate in the nation, quietly began a small and unusual pilot ...
The Express Tribune2h
Study finds link between Ozempic and increased risk of vision loss
People taking Ozempic and Wegovy, which contain the drug semaglutide, may be at an increased risk of developing a ...
The Root on MSN10d
5 Inconvenient Truths About Ozempic, Wegovy and Other Semaglutides, According to Doctors
On Nov. 26, the Biden administration announced a plan to require Medicare and Medicaid to cover weight loss medications like ...
Europe allows Novo to include reduction of kidney disease in Ozempic label
The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the ...
Health on MSN9d
Can’t Afford Ozempic, Other GLP-1 Drugs? Here’s What to Do, According to Experts
More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...